Provided by Tiger Trade Technology Pte. Ltd.

GH Research PLC

15.42
-0.1750-1.12%
Post-market: 15.420.00000.00%17:48 EST
Volume:99.96K
Turnover:1.54M
Market Cap:956.49M
PE:-21.03
High:15.93
Open:15.50
Low:15.13
Close:15.60
52wk High:19.51
52wk Low:7.98
Shares:62.03M
Float Shares:20.47M
Volume Ratio:0.56
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7332
EPS(LYR):-0.7488
ROE:-17.86%
ROA:-14.18%
PB:3.28
PE(LYR):-20.59

Loading ...

Analysts Are Bullish on Top Healthcare Stocks: GH Research (GHRS), Viking Therapeutics (VKTX)

TIPRANKS
·
Jan 29

RBC Capital Remains a Buy on GH Research (GHRS)

TIPRANKS
·
Jan 23

GH Research to Join RBC Capital Markets Psychedelics Symposium Panel

Reuters
·
Jan 22

GH Research Up Over 18%, On Track for Largest Percent Increase Since February 2025 -- Data Talk

Dow Jones
·
Jan 08

GH Research Plc : Needham Raises Target Price to $29 From $19

THOMSON REUTERS
·
Jan 06

BUZZ-U.S. STOCKS ON THE MOVE-Synchrony Financial, Coinbase, Versant Media Group

Reuters
·
Jan 06

Sector Update: Health Care Stocks Lower Premarket Monday

MT Newswires Live
·
Jan 05

BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Liberty Energy, Fortive

Reuters
·
Jan 05

A small company can now advance its psychedelic into Phase 3. Here's why that matters to other psychedelic biotechs.

Dow Jones
·
Jan 05

GH Research Plc : RBC Raises Target Price to $33 From $29

THOMSON REUTERS
·
Jan 05

GH Research Shares Jump 44% Premarket After US FDA Lifts Clinical Hold on Depression Drug Trials

THOMSON REUTERS
·
Jan 05

NextEra Energy, GH Research And 3 Stocks To Watch Heading Into Monday

Benzinga
·
Jan 05

GH Research plc Unveils Data on Ultra-Rapid Antidepressant GH001 in Treatment-Resistant Depression

Reuters
·
Jan 05

FDA Lifts Clinical Hold on GH Research's GH001, Allowing U.S. Trials

Reuters
·
Jan 05

GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026

THOMSON REUTERS
·
Jan 05

GH Research Plc - Phase 3 Initiation Targeted for 2026

THOMSON REUTERS
·
Jan 05

GH Research Plc: Company to Seek FDA Alignment on Global Phase 3 Program Replicating Phase 2B Design

THOMSON REUTERS
·
Jan 05

NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM

Reuters
·
Jan 05

Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Benzinga_recent_news
·
Jan 05

We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth

Simply Wall St.
·
Dec 11, 2025